Nimbus Therapeutics Announces $65 Million in New Financing to Accelerate Pipeline Progress and Expand Discovery Efforts
6/5/18: Each of the company’s current investors participated in the financing, including Atlas Venture, SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures, and Schrödinger. Bruce Booth, Partner of Atlas Venture, Board Chair and co-founder of Nimbus noted, “this round of investment reflects the existing syndicate’s strong and enthusiastic support for Nimbus’ proven management team and exciting new programs.”
Nimbus Therapeutics Enters into Strategic Partnership with Charles River Laboratories to Advance New Therapeutic Programs
Strategic Partnership with Charles River Laboratories Nimbus Therapeutics and Charles River Laboratories International, Inc. (NYSE: CRL) today launched...